Literature DB >> 10482978

How can oncogenic transcription factors cause cancer: a critical review of the myb story.

M Introna1, J Golay.   

Abstract

Many transcription factors have been found to be oncogenic either when functionally altered through fusion with other proteins or through deregulated expression. However, still little is understood about the mechanism by which these proteins can transform cells of different origin. The Myb transcription factor is emblematic in this respect. Several forms of Myb can transform hematopoietic cells of different lineages in the chicken and Myb has been shown to be required for murine fetal hematopoiesis and to regulate the growth and differentiation of hematopoietic cells of several animal species. The role of the transcriptional activity of Myb and its possible gene targets in transformation are critically discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482978     DOI: 10.1038/sj.leu.2401492

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  10 in total

Review 1.  The possible role and application of WT1 in human leukemia.

Authors:  Z Chen
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

2.  Extensively hydrated but folded: a novel state of globular proteins stabilized at high pressure and low temperature.

Authors:  Sunilkumar Puthenpurackal Narayanan; Akihiro Maeno; Hiroshi Matsuo; Masayuki Oda; Hisayuki Morii; Kazuyuki Akasaka
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

3.  The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target.

Authors:  Xi Liu; Kathryn A Gold; Ethan Dmitrovsky
Journal:  Mol Cancer Ther       Date:  2015-05-20       Impact factor: 6.261

4.  Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.

Authors:  Onat Kadioglu; Mohamed Saeed; Nuha Mahmoud; Shaymaa Azawi; Kristin Mrasek; Thomas Liehr; Thomas Efferth
Journal:  Arch Toxicol       Date:  2021-01-30       Impact factor: 5.153

5.  REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer.

Authors:  Mingzhu Zhu; Chun-Chi Liu; Chao Cheng
Journal:  BMC Genomics       Date:  2013-07-26       Impact factor: 3.969

6.  The pan-cancer pathological regulatory landscape.

Authors:  Matias M Falco; Marta Bleda; José Carbonell-Caballero; Joaquín Dopazo
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

7.  Systematic identification of transcription factors associated with patient survival in cancers.

Authors:  Chao Cheng; Lei M Li; Pedro Alves; Mark Gerstein
Journal:  BMC Genomics       Date:  2009-05-15       Impact factor: 3.969

8.  En masse nascent transcription analysis to elucidate regulatory transcription factors.

Authors:  Jinshui Fan; Ming Zhan; Jikui Shen; Jennifer L Martindale; Xiaoling Yang; Tomoko Kawai; Myriam Gorospe
Journal:  Nucleic Acids Res       Date:  2006-03-15       Impact factor: 16.971

9.  The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.

Authors:  Hong Zhou; Joseph Manthey; Ekaterina Lioutikova; William Yang; Kenji Yoshigoe; Mary Qu Yang; Hong Wang
Journal:  Hum Genomics       Date:  2016-07-25       Impact factor: 4.639

10.  Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.

Authors:  Simona D'Aguanno; Elisabetta Valentini; Maria Grazia Tupone; Marianna Desideri; Marta Di Martile; Manuela Spagnuolo; Simonetta Buglioni; Cristiana Ercolani; Italia Falcone; Marco De Dominici; Michele Milella; Maria Giulia Rizzo; Bruno Calabretta; Carlo Cota; Andrea Anichini; Daniela Trisciuoglio; Donatella Del Bufalo
Journal:  J Exp Clin Cancer Res       Date:  2018-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.